
Laura K. Tso
Examiner (ID: 1977, Phone: (571)272-2385 , Office: P/2875 )
| Most Active Art Unit | 2875 |
| Art Unit(s) | 2875, 3303, 3302, 2109, 2831, 2103 |
| Total Applications | 3051 |
| Issued Applications | 2669 |
| Pending Applications | 113 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7241180
[patent_doc_number] => 20040158054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Di-ribonucleotides as specific viral RNA-polymerase inhibitors for the treatment or prevention of viral infections'
[patent_app_type] => new
[patent_app_number] => 10/360218
[patent_app_country] => US
[patent_app_date] => 2003-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6834
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20040158054.pdf
[firstpage_image] =>[orig_patent_app_number] => 10360218
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/360218 | Di-ribonucleotides as specific viral RNA-polymerase inhibitors for the treatment or prevention of viral infections | Feb 6, 2003 | Abandoned |
Array
(
[id] => 1089359
[patent_doc_number] => 06828310
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-07
[patent_title] => 'Compositions including reduced malto-oligosaccharide preserving agents, and methods for preserving a material'
[patent_app_type] => B2
[patent_app_number] => 10/360538
[patent_app_country] => US
[patent_app_date] => 2003-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7968
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/828/06828310.pdf
[firstpage_image] =>[orig_patent_app_number] => 10360538
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/360538 | Compositions including reduced malto-oligosaccharide preserving agents, and methods for preserving a material | Feb 5, 2003 | Issued |
Array
(
[id] => 7361899
[patent_doc_number] => 20040014716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Composition for soluble films with a new hydrolyzed polysaccharide'
[patent_app_type] => new
[patent_app_number] => 10/344117
[patent_app_country] => US
[patent_app_date] => 2003-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1641
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014716.pdf
[firstpage_image] =>[orig_patent_app_number] => 10344117
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/344117 | Composition for soluble films with a new hydrolyzed polysaccharide | Feb 5, 2003 | Abandoned |
Array
(
[id] => 6740778
[patent_doc_number] => 20030158147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Method for treating pain'
[patent_app_type] => new
[patent_app_number] => 10/355699
[patent_app_country] => US
[patent_app_date] => 2003-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8934
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158147.pdf
[firstpage_image] =>[orig_patent_app_number] => 10355699
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/355699 | Method for treating pain | Jan 30, 2003 | Issued |
Array
(
[id] => 1093514
[patent_doc_number] => 06825339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-30
[patent_title] => 'Apparatus for preparing polynucleotides on a solid support'
[patent_app_type] => B2
[patent_app_number] => 10/352704
[patent_app_country] => US
[patent_app_date] => 2003-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9390
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/825/06825339.pdf
[firstpage_image] =>[orig_patent_app_number] => 10352704
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/352704 | Apparatus for preparing polynucleotides on a solid support | Jan 27, 2003 | Issued |
Array
(
[id] => 6847439
[patent_doc_number] => 20030166606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => '5\'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients'
[patent_app_type] => new
[patent_app_number] => 10/333984
[patent_app_country] => US
[patent_app_date] => 2003-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6600
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166606.pdf
[firstpage_image] =>[orig_patent_app_number] => 10333984
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/333984 | 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients | Jan 25, 2003 | Abandoned |
Array
(
[id] => 6847443
[patent_doc_number] => 20030166610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Nutritional composition'
[patent_app_type] => new
[patent_app_number] => 10/350092
[patent_app_country] => US
[patent_app_date] => 2003-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3311
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166610.pdf
[firstpage_image] =>[orig_patent_app_number] => 10350092
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/350092 | Nutritional composition | Jan 23, 2003 | Abandoned |
Array
(
[id] => 1028119
[patent_doc_number] => 06881836
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-19
[patent_title] => 'Photocleavable protecting groups and methods for their use'
[patent_app_type] => utility
[patent_app_number] => 10/348917
[patent_app_country] => US
[patent_app_date] => 2003-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 9219
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/881/06881836.pdf
[firstpage_image] =>[orig_patent_app_number] => 10348917
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/348917 | Photocleavable protecting groups and methods for their use | Jan 21, 2003 | Issued |
Array
(
[id] => 6834694
[patent_doc_number] => 20030162240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Chromogenic substrates of sialidase and methods of making and using the same'
[patent_app_type] => new
[patent_app_number] => 10/348668
[patent_app_country] => US
[patent_app_date] => 2003-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12876
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162240.pdf
[firstpage_image] =>[orig_patent_app_number] => 10348668
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/348668 | Chromogenic substrates of sialidase and methods of making and using the same | Jan 20, 2003 | Issued |
Array
(
[id] => 6843619
[patent_doc_number] => 20030148966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Method and composition for inducing apoptosis in cells'
[patent_app_type] => new
[patent_app_number] => 10/347990
[patent_app_country] => US
[patent_app_date] => 2003-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10290
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20030148966.pdf
[firstpage_image] =>[orig_patent_app_number] => 10347990
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/347990 | Method and composition for inducing apoptosis in cells | Jan 19, 2003 | Abandoned |
| 10/332503 | Adenosine compound and pharmaceutical composition containing the same | Jan 7, 2003 | Abandoned |
Array
(
[id] => 6822132
[patent_doc_number] => 20030220293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Fenofibrate-cyclodextrin inclusion complexes and their pharmaceutical composition'
[patent_app_type] => new
[patent_app_number] => 10/338562
[patent_app_country] => US
[patent_app_date] => 2003-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4570
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20030220293.pdf
[firstpage_image] =>[orig_patent_app_number] => 10338562
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/338562 | Fenofibrate-cyclodextrin inclusion complexes and their pharmaceutical composition | Jan 6, 2003 | Issued |
Array
(
[id] => 6788112
[patent_doc_number] => 20030139351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'NKT cell-activating agents containing alpha-glycosylceramides'
[patent_app_type] => new
[patent_app_number] => 10/334861
[patent_app_country] => US
[patent_app_date] => 2003-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12086
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20030139351.pdf
[firstpage_image] =>[orig_patent_app_number] => 10334861
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/334861 | NKT cell-activating agents containing -glycosylceramides | Jan 1, 2003 | Issued |
Array
(
[id] => 6796453
[patent_doc_number] => 20030175327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Hemostatic compositions and methods for controlling bleeding'
[patent_app_type] => new
[patent_app_number] => 10/334864
[patent_app_country] => US
[patent_app_date] => 2002-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9127
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175327.pdf
[firstpage_image] =>[orig_patent_app_number] => 10334864
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/334864 | Hemostatic compositions and methods for controlling bleeding | Dec 30, 2002 | Issued |
Array
(
[id] => 6830633
[patent_doc_number] => 20030181691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Chromogenic substrates of sialidase and methods of making and using the same'
[patent_app_type] => new
[patent_app_number] => 10/328790
[patent_app_country] => US
[patent_app_date] => 2002-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12785
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181691.pdf
[firstpage_image] =>[orig_patent_app_number] => 10328790
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/328790 | Chromogenic substrates of sialidase and methods of making and using the same | Dec 23, 2002 | Issued |
Array
(
[id] => 6797517
[patent_doc_number] => 20030176391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Oral fludara of high-purity formulation with quick release of active ingredient'
[patent_app_type] => new
[patent_app_number] => 10/324141
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4771
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176391.pdf
[firstpage_image] =>[orig_patent_app_number] => 10324141
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/324141 | Oral fludara of high-purity formulation with quick release of active ingredient | Dec 19, 2002 | Issued |
Array
(
[id] => 6707010
[patent_doc_number] => 20030153744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Anti-viral 7-deaza L-nucleosides'
[patent_app_type] => new
[patent_app_number] => 10/326573
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4331
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20030153744.pdf
[firstpage_image] =>[orig_patent_app_number] => 10326573
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/326573 | Anti-viral 7-deaza L-nucleosides | Dec 19, 2002 | Abandoned |
Array
(
[id] => 7305937
[patent_doc_number] => 20040116362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Novel nucleosides and related processes, pharmaceutical compositions and methods'
[patent_app_type] => new
[patent_app_number] => 10/321133
[patent_app_country] => US
[patent_app_date] => 2002-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18650
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20040116362.pdf
[firstpage_image] =>[orig_patent_app_number] => 10321133
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/321133 | Nucleosides and related processes, pharmaceutical compositions and methods | Dec 16, 2002 | Issued |
Array
(
[id] => 7964093
[patent_doc_number] => 06680381
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-20
[patent_title] => 'Recovery of isoflavones from soy molasses'
[patent_app_type] => B1
[patent_app_number] => 10/320792
[patent_app_country] => US
[patent_app_date] => 2002-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8620
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/680/06680381.pdf
[firstpage_image] =>[orig_patent_app_number] => 10320792
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/320792 | Recovery of isoflavones from soy molasses | Dec 15, 2002 | Issued |
Array
(
[id] => 7632951
[patent_doc_number] => 06664382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-12-16
[patent_title] => 'Recovery of isoflavones from soy molasses'
[patent_app_type] => B2
[patent_app_number] => 10/319730
[patent_app_country] => US
[patent_app_date] => 2002-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8613
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/664/06664382.pdf
[firstpage_image] =>[orig_patent_app_number] => 10319730
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/319730 | Recovery of isoflavones from soy molasses | Dec 12, 2002 | Issued |